[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI892640A - Förfarande för framställning av en piperidinoalkanol-ibuprofenkomposition innehållande farmaceutisk komposition - Google Patents

Förfarande för framställning av en piperidinoalkanol-ibuprofenkomposition innehållande farmaceutisk komposition Download PDF

Info

Publication number
FI892640A
FI892640A FI892640A FI892640A FI892640A FI 892640 A FI892640 A FI 892640A FI 892640 A FI892640 A FI 892640A FI 892640 A FI892640 A FI 892640A FI 892640 A FI892640 A FI 892640A
Authority
FI
Finland
Prior art keywords
piperidinoalkanol
preparing
pharmaceutical composition
ibuprofen combination
ibuprofen
Prior art date
Application number
FI892640A
Other languages
English (en)
Finnish (fi)
Other versions
FI90205C (sv
FI90205B (sv
FI892640A0 (sv
Inventor
Herbert Schock
David Francis Long
William Richard Nadler
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI892640A0 publication Critical patent/FI892640A0/sv
Publication of FI892640A publication Critical patent/FI892640A/sv
Application granted granted Critical
Publication of FI90205B publication Critical patent/FI90205B/sv
Publication of FI90205C publication Critical patent/FI90205C/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI892640A 1988-06-01 1989-05-31 Förfarande för framställning av en piperidinoalkanol-ibuprofenkomposition innehållande farmaceutisk komposition FI90205C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20081788A 1988-06-01 1988-06-01
US20081788 1988-06-01
US34418389 1989-04-27
US07/344,183 US4999226A (en) 1988-06-01 1989-04-27 Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination

Publications (4)

Publication Number Publication Date
FI892640A0 FI892640A0 (sv) 1989-05-31
FI892640A true FI892640A (sv) 1989-12-02
FI90205B FI90205B (sv) 1993-09-30
FI90205C FI90205C (sv) 1994-01-10

Family

ID=26896133

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892640A FI90205C (sv) 1988-06-01 1989-05-31 Förfarande för framställning av en piperidinoalkanol-ibuprofenkomposition innehållande farmaceutisk komposition

Country Status (17)

Country Link
US (1) US4999226A (sv)
EP (1) EP0348683B1 (sv)
JP (1) JP2757017B2 (sv)
KR (1) KR0126129B1 (sv)
CN (1) CN1038021A (sv)
AU (1) AU615751B2 (sv)
CA (1) CA1327011C (sv)
DE (1) DE68900378D1 (sv)
DK (1) DK174638B1 (sv)
ES (1) ES2037908T3 (sv)
FI (1) FI90205C (sv)
GR (1) GR3003477T3 (sv)
HU (1) HU202746B (sv)
IE (1) IE61182B1 (sv)
IL (1) IL90461A0 (sv)
NZ (1) NZ229325A (sv)
PT (1) PT90689B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
JPH069382A (ja) * 1992-04-17 1994-01-18 Takeda Chem Ind Ltd 安定化された固型製剤およびその製造方法
JPH08506808A (ja) * 1992-12-21 1996-07-23 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸障害治療用組成物の製造における鎮痛剤s(+)対掌体の利用
KR100337985B1 (ko) * 1993-06-14 2002-11-23 얀센 파마슈티카 엔.브이. 아스테미졸및슈도에페드린의서방성필름-코팅정제
US5691352A (en) * 1993-10-25 1997-11-25 Merrell Pharmaceuticals Inc. Stable pharmaceutical composition of terfenadine and ibuprofen
PT812589E (pt) * 1993-12-10 2000-11-30 Fujisawa Pharmaceutical Co "farmaco combinado antipiretico e analgesico"
US5419917A (en) * 1994-02-14 1995-05-30 Andrx Pharmaceuticals, Inc. Controlled release hydrogel formulation
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
HUP9802086A3 (en) * 1995-02-28 2001-02-28 Aventis Pharmaceuticals Inc Br Pharmaceutical composition for piperidinoalkanol compounds
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
CA2428817C (en) * 2000-11-17 2010-06-01 Takeda Chemical Industries, Ltd. Copolyvidone-containing preparation
MXPA04002976A (es) * 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosificacion con un nucleo interior y una cobertura externa.
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
US20050220877A1 (en) * 2004-03-31 2005-10-06 Patel Ashish A Bilayer tablet comprising an antihistamine and a decongestant
CN1993111A (zh) * 2004-05-21 2007-07-04 阿库-伯雷克技术公司 含有相对无活性片段的药片
CA2565029C (en) * 2004-05-21 2013-09-03 Lawrence Solomon Immediate release pharmaceutical tablets with height greater than width
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
WO2007073702A2 (es) 2005-12-29 2007-07-05 Osmotica Corp. Comprimido multicapa con combinación de triple liberación
WO2010078542A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
CA2748728C (en) * 2009-01-05 2017-01-03 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
US8252330B2 (en) 2009-01-05 2012-08-28 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
US20130115250A1 (en) * 2009-05-13 2013-05-09 Wyeth Llc Burst Drug Release Compositions
RU2764849C2 (ru) 2016-12-09 2022-01-21 Байер Энимэл Хельс ГмбХ Фармацевтический препарат и способ его получения
CN108703828B (zh) * 2018-06-04 2021-03-30 王荣涛 下肢牵引器
CN109481272B (zh) * 2019-01-10 2020-07-24 河南省洛阳正骨医院(河南省骨科医院) 肺癌骨转移术后康复装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
US4882167A (en) * 1983-05-31 1989-11-21 Jang Choong Gook Dry direct compression compositions for controlled release dosage forms
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method

Also Published As

Publication number Publication date
HUT52367A (en) 1990-07-28
ES2037908T3 (es) 1993-07-01
DK265489D0 (da) 1989-05-31
IE61182B1 (en) 1994-10-05
FI90205C (sv) 1994-01-10
AU615751B2 (en) 1991-10-10
IL90461A0 (en) 1990-01-18
IE891795L (en) 1989-12-01
NZ229325A (en) 1990-10-26
PT90689A (pt) 1989-12-29
US4999226A (en) 1991-03-12
HU202746B (en) 1991-04-29
GR3003477T3 (en) 1993-02-17
KR0126129B1 (ko) 1997-12-24
FI90205B (sv) 1993-09-30
AU3580089A (en) 1989-12-07
JP2757017B2 (ja) 1998-05-25
DE68900378D1 (de) 1991-12-05
EP0348683A1 (en) 1990-01-03
PT90689B (pt) 1993-12-31
CN1038021A (zh) 1989-12-20
FI892640A0 (sv) 1989-05-31
EP0348683B1 (en) 1991-10-30
DK265489A (da) 1989-12-02
DK174638B1 (da) 2003-08-04
KR900017573A (ko) 1990-12-19
JPH0228111A (ja) 1990-01-30
CA1327011C (en) 1994-02-15

Similar Documents

Publication Publication Date Title
FI892640A (sv) Förfarande för framställning av en piperidinoalkanol-ibuprofenkomposition innehållande farmaceutisk komposition
FI894637A (sv) Förfarande för framställning av en farmaceutisk beredning omfattande en mikroemulsion
FI102458B1 (sv) Förfarande för framställning av en topikal farmaceutisk sammansättning
FI881978A (sv) Förfarande för framställning av en farmaceutisk sammansättning, som innehåller eperison
FI894342A (sv) Förfarande för framställning av en cyklosporin innehållande farmaceutisk sammansättning
HUT50851A (en) Process for producing intervenous pharmaceutical compositions
EP0428268A3 (en) Pharmaceutical phenylpyridone derivatives
PT86986A (pt) Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments
DK489189A (da) Farmaceutisk praeparat
FI883261A (sv) Förfarande för framställning av en farmaceutisk komposition innefattande en somatostatinanalog
PT91631A (pt) A process for the preparation of cyclic graf-analogs ii
ZA895838B (en) Pharmaceutical compounds
NO901232L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
GB8800891D0 (en) Pharmaceutical compounds
FI98127C (sv) Förfarande för framställning av en stabiliserad farmaceutisk komposition
DK603988D0 (da) Farmaceutisk praeparat
PT87672A (pt) Process for preparing a pharmaceutical composition
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
DK336489A (da) Farmaceutisk praeparat
PT87564A (pt) Process for preparing substituted vinylcephalosporins useful as medicaments
FI101600B1 (sv) Förfarande för framställning av en farmaceutiskt formulation
PT87186A (pt) Imidazothiadiazine derivatives a process for preparing the same and their use as medicaments
NO902460L (no) Fremgangsmaate for fremstilling av en natriumpolyacrylatgel
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
GB9123241D0 (en) A process for preparing a pharmaceutical composition

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: MERRELL DOW PHARMACEUTICALS INC.

PC Transfer of assignment of patent

Owner name: AVENTIS INC.

Free format text: AVENTIS INC.

MA Patent expired